Cargando…

Breast Cancer Organoids Model Patient-Specific Response to Drug Treatment

SIMPLE SUMMARY: The possibility to generate in the laboratory faithful models of patients’ tumors is of primary importance to capture cancer complexity and study therapy response in a personalized setting. Tumor organoids are 3D cell cultures, obtained from patients’ tumor tissues, that recapitulate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campaner, Elena, Zannini, Alessandro, Santorsola, Mariangela, Bonazza, Deborah, Bottin, Cristina, Cancila, Valeria, Tripodo, Claudio, Bortul, Marina, Zanconati, Fabrizio, Schoeftner, Stefan, Del Sal, Giannino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770601/ https://www.ncbi.nlm.nih.gov/pubmed/33371412 http://dx.doi.org/10.3390/cancers12123869

Ejemplares similares

TGS1 mediates 2,2,7-trimethyl guanosine capping of the human telomerase RNA to direct telomerase dependent telomere maintenance
por: Buemi, Valentina, et al.
Publicado: (2022)

Oncogenic Hijacking of the PIN1 Signaling Network
por: Zannini, Alessandro, et al.
Publicado: (2019)

FUS-dependent loading of SUV39H1 to OCT4 pseudogene-lncRNA programs a silencing complex with OCT4 promoter specificity
por: Scarola, Michele, et al.
Publicado: (2020)

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
por: Sobhani, Navid, et al.
Publicado: (2018)

Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells
por: Lisek, Kamil, et al.
Publicado: (2018)

Association between benign thyroid disease and breast cancer: a single center experience
por: Dobrinja, Chiara, et al.
Publicado: (2019)

A Case–Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection
por: Bortul, Marina, et al.
Publicado: (2023)

Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma
por: D’Angelo, Alberto, et al.
Publicado: (2019)

Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth
por: Tombari, Camilla, et al.
Publicado: (2023)

Author Correction: Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth
por: Tombari, Camilla, et al.
Publicado: (2023)

Evaluation of region selective bilirubin-induced brain damage as a basis for a pharmacological treatment
por: Dal Ben, Matteo, et al.
Publicado: (2017)

Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer
por: Sobhani, Navid, et al.
Publicado: (2018)

An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast Cancer
por: Tierno, Domenico, et al.
Publicado: (2023)

Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome
por: Capaci, Valeria, et al.
Publicado: (2020)

Pseudotemporal ordering of spatial lymphoid tissue microenvironment profiles trails Unclassified DLBCL at the periphery of the follicle
por: Tripodo, Claudio, et al.
Publicado: (2023)

A mutant p53/Hif1α/miR-30d axis reprograms the secretory pathway promoting the release of a prometastatic secretome
por: Capaci, Valeria, et al.
Publicado: (2020)

Amplifying Tumor–Stroma Communication: An Emerging Oncogenic Function of Mutant p53
por: Capaci, Valeria, et al.
Publicado: (2021)

Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications
por: Tierno, Domenico, et al.
Publicado: (2023)

MDP, a database linking drug response data to genomic information, identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cells
por: Taccioli, Cristian, et al.
Publicado: (2015)

Sterol regulatory element binding protein 1 couples mechanical cues and lipid metabolism
por: Bertolio, Rebecca, et al.
Publicado: (2019)

Usefulness of core needle biopsy for the diagnosis of thyroid Burkitt’s lymphoma: a case report and review of the literature
por: Bernardi, Stella, et al.
Publicado: (2018)

Bilirubin-Induced Transcriptomic Imprinting in Neonatal Hyperbilirubinemia
por: Llido, John Paul, et al.
Publicado: (2023)

HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness
por: Pupa, Serenella M., et al.
Publicado: (2021)

No Clear Clustering Dysbiosis from Salivary Microbiota Analysis by Long Sequencing Reads in Patients Affected by Oral Squamous Cell Carcinoma: A Single Center Study
por: Mauceri, Rodolfo, et al.
Publicado: (2023)

Histone acetylation as a new mechanism for bilirubin-induced encephalopathy in the Gunn rat
por: Vianello, Eleonora, et al.
Publicado: (2018)

Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc
por: D'Artista, Luana, et al.
Publicado: (2016)

Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis
por: Giudici, Fabiola, et al.
Publicado: (2019)

Correction: Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis
por: Giudici, Fabiola, et al.
Publicado: (2019)

p73 as a Pharmaceutical Target for Cancer Therapy
por: Bisso, Andrea, et al.
Publicado: (2011)

Mutant p53: One, No One, and One Hundred Thousand
por: Walerych, Dawid, et al.
Publicado: (2015)

Mutant p53 as a guardian of the cancer cell
por: Mantovani, Fiamma, et al.
Publicado: (2018)

Complexes formed by mutant p53 and their roles in breast cancer
por: Bellazzo, Arianna, et al.
Publicado: (2018)

Comparison between male and female breast cancer survival using propensity score matching analysis
por: Scomersi, Serena, et al.
Publicado: (2021)

Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics Analysis Involving Human Carcinomas
por: Mangogna, Alessandro, et al.
Publicado: (2019)

Pathological Significance and Prognostic Value of Surfactant Protein D in Cancer
por: Mangogna, Alessandro, et al.
Publicado: (2018)

Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma
por: Cascini, Caterina, et al.
Publicado: (2023)

Prognostic Implications of the Complement Protein C1q in Gliomas
por: Mangogna, Alessandro, et al.
Publicado: (2019)

Glucocorticoid receptor signalling activates YAP in breast cancer
por: Sorrentino, Giovanni, et al.
Publicado: (2017)

The rebel angel: mutant p53 as the driving oncogene in breast cancer
por: Walerych, Dawid, et al.
Publicado: (2012)

Wiring the oncogenic circuitry: Pin1 unleashes mutant p53
por: Napoli, Marco, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_duli8ii7i61civpcqotqdnqgp9